SavedAdd your journal

Journals / Osmangazi Tıp Dergisi / 2026 / Cilt: 48 Sayı: 3

Evaluation of Inflammatory and Thrombotic Risk after Endovenous Laser Ablation in Patients with Chronic Venous Insufficiency

Kronik Venöz Yetmezlik Nedeniyle Endovenoz Lazer Ablasyon Uygulanan Hastalarda İnflamasyon ve Tromboz Risklerinin Araştırılması

Tarık Taştekin(Burdur Devlet Hastanesi)0000-0003-4919-9981
Hamdi Mehmet Özbek(Sincan Eğitim ve Araştırma Hastanesi)0000-0003-0044-8182
Pages
449–453
Publication Date
2026-05-12
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

EVLA induces transient inflammatory and thrombotic changes that tend to normalize by postoperative day 10, supporting the overall safety of the procedure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Chronic venous insufficiency (CVI) is a common vascular disorder, and endovenous laser ablation (EVLA) is a widely used minimally invasive treatment.
📊
Key Findings & Data:This study aimed to evaluate perioperative changes in inflammatory and thrombotic markers following EVLA.This retrospective study included patients who underwent EVLA for CVI at Burdur State Hospital between January and September 2025.
💡
Conclusion & Impact:EVLA induces transient inflammatory and thrombotic changes that tend to normalize by postoperative day 10, supporting the overall safety of the procedure.
🔬Design:Araştırma Makalesi
📍Scope:2025 Verileri
⚙️Variables:Kronik venöz yetmezlik · endovenöz lazer ablasyon · ortalama trombosit hacmi

Abstract

Chronic venous insufficiency (CVI) is a common vascular disorder, and endovenous laser ablation (EVLA) is a widely used minimally invasive treatment. This study aimed to evaluate perioperative changes in inflammatory and thrombotic markers following EVLA.This retrospective study included patients who underwent EVLA for CVI at Burdur State Hospital between January and September 2025. Fibrinogen, D-dimer, C-reactive protein (CRP), platelet count (PLT), mean platelet volume (MPV), hemoglobin (Hb), and hematocrit (Hct) were recorded preoperatively and on postoperative days 1 and 10. Statistical analyses were performed using paired t-tests or Wilcoxon signed-rank tests. A total of 24 patients were included in the study. The mean age was 48.4 ± 11.6 years (range: 27–72), with an equal distribution of females (n=12, 50%) and males (n=12, 50%). D-dimer levels increased significantly on postoperative day 1 (p <0.001) and decreased by day 10 (p <0.001). Fibrinogen levels showed no significant change on day 1 but increased by postoperative day 10 (p = 0.018). CRP levels increased on postoperative day 1 (p <0.001) and returned toward baseline by day 10 (p=0.107). MPV decreased on day 1 (p = 0.004) and increased by day 10 (p = 0.047). PLT declined on day 1 (p <0.001) and normalized by day 10, while Hb and Hct showed transient postoperative decreases. EVLA induces transient inflammatory and thrombotic changes that tend to normalize by postoperative day 10, supporting the overall safety of the procedure.

Özet

Kronik venöz yetmezlik (KVY) sık görülen bir damar hastalığıdır ve endovenöz lazer ablasyon (EVLA) yaygın olarak kullanılan minimal invaziv bir tedavi yöntemidir. Bu çalışmada, EVLA uygulanan hastalarda perioperatif dönemde inflamatuvar ve trombotik belirteçlerdeki değişimlerin değerlendirilmesi amaçlandı Bu retrospektif çalışmaya, Ocak–Eylül 2025 tarihleri arasında Burdur Devlet Hastanesi’nde KVY nedeniyle EVLA uygulanan hastalar dahil edildi. Fibrinojen, D-dimer, C-reaktif protein (CRP), trombosit sayısı (PLT), ortalama trombosit hacmi (MPV), hemoglobin (Hb) ve hematokrit (Hct) düzeyleri preoperatif, postoperatif 1. gün ve 10. günde kaydedildi. İstatistiksel analizlerde eşleştirilmiş t-testi veya Wilcoxon işaretli sıralar testi kullanıldı. Çalışmaya toplam 24 hasta dahil edildi. Hastaların yaş ortalaması 48.4 ± 11.6 yıl olup (27–72), cinsiyet dağılımı %50 kadın (n=12) ve %50 erkek (n=12) şeklindeydi. D-dimer düzeyleri postoperatif 1. günde anlamlı olarak artarken (p<0,001), 10. günde azalma gösterdi (p<0,001). Fibrinojen düzeylerinde 1. günde anlamlı değişiklik izlenmezken, 10. günde anlamlı artış saptandı (p=0,018). CRP düzeyleri 1. günde yükseldi (p<0,001) ve 10. günde başlangıç değerlerine yaklaştı (p=0,107). MPV 1. günde azalırken (p=0,004), 10. günde artış gösterdi (p=0,047). PLT 1. günde azalmakla birlikte 10. günde normale döndü; Hb ve Hct değerlerinde ise geçici postoperatif düşüş izlendi. EVLA sonrası erken dönemde inflamatuvar ve trombotik belirteçlerde geçici değişiklikler meydana gelmekte olup, bu değişiklikler 10. gün itibarıyla büyük ölçüde normale dönmektedir. Bu bulgular EVLA’nın güvenilirliğini desteklemektedir.

🔖

Cite This Article

Taştekin, T., Özbek, H. M. (2026). Evaluation of Inflammatory and Thrombotic Risk after Endovenous Laser Ablation in Patients with Chronic Venous Insufficiency. Osmangazi Tıp Dergisi, Cilt: 48 Sayı: 3, 449–453. https://doi.org/10.20515/otd.1805048

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Ortega MA, Fraile-Martínez O, García-Montero C, Álvarez-Mon MA, Chaowen C, Ruiz-Grande F, et al. Understanding Chronic Venous Disease: A Critical Overview of Its Pathophysiology and Medical Management. J Clin Med. 2021;10(15).
  2. Karathanos C, Spanos K, Batzalexis K, Nana P, Kouvelos G, Rousas N, et al. Prospective comparative study of different endovenous thermal ablation systems for treatment of great saphenous vein reflux. J Vasc Surg Venous Lymphat Disord. 2021;9(3):660-8.
  3. El Kilic H, Bektas N, Bitargil M, Balkaya IA, Demir T, Koramaz I. Long-term outcomes of endovenous laser ablation, n-butyl cyanoacrylate, and radiofrequency ablation for treatment of chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022;10(4):865-71.
  4. Pavei P, Spreafico G, Bernardi E, Giraldi E, Ferrini M. Favorable long-term results of endovenous laser ablation of great and small saphenous vein incompetence with a 1470-nm laser and radial fiber. J Vasc Surg Venous Lymphat Disord. 2021;9(2):352-60.
  5. Eggen CAM, Alozai T, Pronk P, Mooij MC, Gaastra MTW, Ünlü Ç, et al. Ten-year follow-up of a randomized controlled trial comparing saphenofemoral ligation and stripping of the great saphenous vein with endovenous laser ablation (980 nm) using local tumescent anesthesia. J Vasc Surg Venous Lymphat Disord. 2022;10(3):646-53.e1.
  6. Arase H, Sugasawa N, Kawatani Y, Sugano M, Kurobe H, Fujimoto E, et al. Appropriate Surgical Treatment of Symptomatic Primary Varicose Veins Decreases Systemic Inflammatory Biomarkers. Ann Vasc Dis. 2019;12(3):367-71.
  7. Keo HH, Knoechel J, Diehm N, Kalka C, Staub D, Gaehwiler R, et al. Venous thrombosis following endovenous laser ablation with and without thromboprophylaxis. J Vasc Surg Venous Lymphat Disord. 2024;12(1):101656.
  8. Keo HH, Spinedi L, Staub D, Diehm N, Holtz D, Broz P, et al. Duration of pharmacological thromboprophylaxis after outpatient endovenous laser ablation: a propensity score-matched analysis. Swiss Med Wkly. 2019;149:w20166.
  9. Kalinin R, Suchkov I, Kamaev A, Mzhavanadze N, Povarov V. Effects of low-energy EVLA with the use of a 1470-nm laser on vascular inflammation and remodeling parameters in patients with chronic venous disease. Lasers in Medical Science. 2025;40(1):516.
  10. Mehmet Akif Sarıca, Betül Kızıldağ, Mustafa Yavuz Selçuk, Ayşe Şahin Tutak, Ali Haydar Baykan, Hacı Taner Bulut, et al. Mean Platelet Volume in Patients with Chronic Venous Insufficiency. Journal of Clinical and Experimental Investigations. 2016;7(1):73-7.
  11. Güven C, Doğukan M. Siyanoakrilat ile Safen Ven Embolizasyonunda Ortalama Trombosit Hacmi ve Trombosit Sayısının Değişimi. Harran Üniversitesi Tıp Fakültesi Dergisi. 2019;16(2):272-9.
  12. Dzieciuchowicz L, Espinosa G, Páramo JA. Haemostatic activation and inflammatory response after three methods of treatment of great saphenous vein incompetence. Phlebology. 2014;29(3):154-63.
  13. Hinterhuber G, Böhler K, Kittler H, Quehenberger P. Extended monitoring of hemostatic activation after varicose vein surgery under general anesthesia. Dermatol Surg. 2006;32(5):632-9.